External

MEG@9I�� Comprehensive Training (Second Edition)

sylvain.baillet@mcgill.ca — Tue, 04 Aug 2015 18:57:34 +0000

It is with great pleasure that we are announcing the 2nd edition of the MEG@9I�� Comprehensive Training Program in 2015.

2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Albert Aguayo Lecture: Unlocking Secrets in Nerve Repair: From Neuronal Signaling to Glial Modulation

admin — Mon, 20 Jan 2025 15:27:51 +0000

This annual lecture honours Dr. Albert Aguayo, OC, FRCP, Professor Emeritus founder and former Director of the Centre for the Research in Neuroscience at 9I��. A cocktail reception will follow the lecture.

Neuro Epilepsy Day and Pierre Gloor Lecture 2025

admin — Tue, 03 Dec 2024 14:37:05 +0000

The Neuro Epilepsy Day is a half-day event. The day will focus on neurodegeration and tauopathy in epilepsy, and its implications for cognition and disease progression.

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

An open solution to improving research reproducibility

admin — Wed, 18 Dec 2024 16:12:19 +0000

Academic and industry scientists collaborate on a new method to characterize research antibodies

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 9I�� and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.